Go Pro
→ America’s answer to universal basic income (From Freedom Financial) (Ad)tc pixel Free KNB Stock Alerts

Kanabo Group (KNB) Competitors

Kanabo Group logo
GBX 0.22 0.00 (0.00%)
As of 07/20/2026
Compare

KNB vs. TLY, SPI, MGP, SBI, and N4P

Should you buy Kanabo Group stock or one of its competitors? MarketBeat compares Kanabo Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Kanabo Group include Totally (TLY), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), and N4 Pharma (N4P). These companies are all part of the "medical" sector.

How does Kanabo Group compare to Totally?

Kanabo Group (LON:KNB) and Totally (LON:TLY) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.

3.8% of Kanabo Group shares are held by institutional investors. Comparatively, 51.3% of Totally shares are held by institutional investors. 24.3% of Kanabo Group shares are held by insiders. Comparatively, 13.3% of Totally shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Totally has a net margin of -2.94% compared to Kanabo Group's net margin of -892.40%. Totally's return on equity of -8.85% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-892.40% -80.03% -20.89%
Totally -2.94%-8.85%-2.42%

In the previous week, Totally had 1 more articles in the media than Kanabo Group. MarketBeat recorded 1 mentions for Totally and 0 mentions for Kanabo Group. Kanabo Group's average media sentiment score of 0.00 equaled Totally'saverage media sentiment score.

Company Overall Sentiment
Kanabo Group Neutral
Totally Neutral

Totally has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Totally, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A
Totally£133.05M0.00-£3.79M-£1.93N/A

Kanabo Group has a beta of 3.04, suggesting that its stock price is 204% more volatile than the broader market. Comparatively, Totally has a beta of 0.55, suggesting that its stock price is 45% less volatile than the broader market.

Summary

Totally beats Kanabo Group on 8 of the 12 factors compared between the two stocks.

How does Kanabo Group compare to Spire Healthcare Group?

Kanabo Group (LON:KNB) and Spire Healthcare Group (LON:SPI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.

Spire Healthcare Group has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A
Spire Healthcare Group£1.58B0.56£28.15M£4.0055.50

Spire Healthcare Group has a consensus price target of GBX 276, suggesting a potential upside of 24.32%. Given Spire Healthcare Group's stronger consensus rating and higher possible upside, analysts plainly believe Spire Healthcare Group is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Spire Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Kanabo Group has a beta of 3.04, meaning that its share price is 204% more volatile than the broader market. Comparatively, Spire Healthcare Group has a beta of 0.928, meaning that its share price is 7% less volatile than the broader market.

3.8% of Kanabo Group shares are owned by institutional investors. Comparatively, 22.9% of Spire Healthcare Group shares are owned by institutional investors. 24.3% of Kanabo Group shares are owned by insiders. Comparatively, 39.3% of Spire Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Spire Healthcare Group has a net margin of 1.04% compared to Kanabo Group's net margin of -892.40%. Spire Healthcare Group's return on equity of 2.22% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-892.40% -80.03% -20.89%
Spire Healthcare Group 1.04%2.22%3.73%

In the previous week, Spire Healthcare Group had 3 more articles in the media than Kanabo Group. MarketBeat recorded 3 mentions for Spire Healthcare Group and 0 mentions for Kanabo Group. Kanabo Group's average media sentiment score of 0.00 equaled Spire Healthcare Group'saverage media sentiment score.

Company Overall Sentiment
Kanabo Group Neutral
Spire Healthcare Group Neutral

Summary

Spire Healthcare Group beats Kanabo Group on 13 of the 15 factors compared between the two stocks.

How does Kanabo Group compare to Medica Group?

Kanabo Group (LON:KNB) and Medica Group (LON:MGP) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment, valuation and dividends.

Medica Group has a net margin of 9.35% compared to Kanabo Group's net margin of -892.40%. Medica Group's return on equity of 12.42% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-892.40% -80.03% -20.89%
Medica Group 9.35%12.42%6.62%

In the previous week, Kanabo Group's average media sentiment score of 0.00 equaled Medica Group'saverage media sentiment score.

Company Overall Sentiment
Kanabo Group Neutral
Medica Group Neutral

Medica Group has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Medica Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A
Medica Group£76.98M0.00£7.20M£0.06N/A

3.8% of Kanabo Group shares are held by institutional investors. Comparatively, 88.4% of Medica Group shares are held by institutional investors. 24.3% of Kanabo Group shares are held by insiders. Comparatively, 2.9% of Medica Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Kanabo Group has a beta of 3.04, suggesting that its stock price is 204% more volatile than the broader market. Comparatively, Medica Group has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market.

Summary

Medica Group beats Kanabo Group on 8 of the 10 factors compared between the two stocks.

How does Kanabo Group compare to Sourcebio International?

Sourcebio International (LON:SBI) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

In the previous week, Sourcebio International's average media sentiment score of 0.00 equaled Kanabo Group'saverage media sentiment score.

Company Overall Sentiment
Sourcebio International Neutral
Kanabo Group Neutral

Sourcebio International has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Sourcebio International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sourcebio International£75.61M0.00N/A£0.09N/A
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A

3.8% of Kanabo Group shares are owned by institutional investors. 24.3% of Kanabo Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Sourcebio International has a net margin of 0.00% compared to Kanabo Group's net margin of -892.40%. Sourcebio International's return on equity of 0.00% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Sourcebio InternationalN/A N/A N/A
Kanabo Group -892.40%-80.03%-20.89%

Summary

Sourcebio International beats Kanabo Group on 6 of the 8 factors compared between the two stocks.

How does Kanabo Group compare to N4 Pharma?

N4 Pharma (LON:N4P) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

0.2% of N4 Pharma shares are held by institutional investors. Comparatively, 3.8% of Kanabo Group shares are held by institutional investors. 22.0% of N4 Pharma shares are held by insiders. Comparatively, 24.3% of Kanabo Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Kanabo Group has a net margin of -892.40% compared to N4 Pharma's net margin of -14,542.71%. Kanabo Group's return on equity of -80.03% beat N4 Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
N4 Pharma-14,542.71% -119.30% -56.00%
Kanabo Group -892.40%-80.03%-20.89%

In the previous week, N4 Pharma's average media sentiment score of 0.00 equaled Kanabo Group'saverage media sentiment score.

Company Overall Sentiment
N4 Pharma Neutral
Kanabo Group Neutral

N4 Pharma has a beta of -0.37, meaning that its stock price is 137% less volatile than the broader market. Comparatively, Kanabo Group has a beta of 3.04, meaning that its stock price is 204% more volatile than the broader market.

N4 Pharma has higher earnings, but lower revenue than Kanabo Group. N4 Pharma is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
N4 Pharma£7.07K800.95-£1.63M-£0.24N/A
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A

Summary

Kanabo Group beats N4 Pharma on 8 of the 11 factors compared between the two stocks.

Get Kanabo Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KNB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KNB vs. The Competition

Export
MetricKanabo GroupMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£1.42M£1.59B£7.01B£2.88B
Dividend YieldN/A3.93%2.67%6.16%
P/E Ratio-0.1612.4726.88368.27
Price / Sales1.2517.95518.3584,379.67
Price / Cash1.827.9050.6027.89
Price / Book0.241.8510.567.61
Net Income-£8.18M£63.03M£3.60B£5.89B
7 Day PerformanceN/A-0.41%-2.15%0.39%
1 Month PerformanceN/A0.61%0.10%-0.64%
1 Year PerformanceN/A15.70%22.55%62.99%

Kanabo Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KNB
Kanabo Group
N/AGBX 0.23
flat		N/AN/A£1.42M£1.14MN/A20
TLY
Totally
N/AGBX 0.25
+4.2%		N/A+0.0%£491K£133.05MN/A1,668
SPI
Spire Healthcare Group
1.7036 of 5 stars		GBX 219
+0.9%		GBX 276
+26.0%		+0.4%£877.31M£1.58B54.75420
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:KNB) was last updated on 7/22/2026 by MarketBeat.com Staff.
From Our Partners
America’s answer to universal basic income
Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...
Freedom Financial | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Elon is about to dominate the biggest arms race in tech history
Microsoft, Amazon, Alphabet, and Meta have collectively poured nearly $700 billion into AI infrastructure in 2...
The Oxford Club | Sponsoredtc pixel
Wall Street legend put 60% in one stock — here’s the ticker
One of America's most famous investors put 60% of his fund into a single stock - and Whitney Tilson of Stansbe...
Stansberry Research | Sponsoredtc pixel
It all happens tonight.
Tonight, trader Sean Allison is hosting a live session to walk through his Zero-Dollar Trade Advantage strateg...
Trade Thirsty | Sponsoredtc pixel
The options guide that actually starts at the beginning
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel